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Introduction. The higher complication rate associated with the surgical treatment of restenosis following carotid
endarterectomy (CEA) has led several authors to advocate angioplasty as the treatment of choice in the management of
restenosis. We describe our experience with internal carotid artery angioplasty for post-endarterectomy restenosis over 7
years.
Patients and methods. From January 1994 to April 2001, all patients with a .90% restenosis following CEA were
considered for angioplasty. Thirty angioplasties were carried out in 25 patients, 80% (24/30), for asymptomatic recurrent
stenosis. There was no difference between those who had intervention for recurrent stenosis (n ¼ 31) and those who did not
(n ¼ 545) in age, sex, smoking status or incidence of diabetes or hypertension. A significantly greater number of patients
who underwent angioplasty were hypercholesterolaemic (p , 0.05, Chi-squared test).
Results. Mean time from surgery to angioplasty was 13 months (range 1–23). Angioplasty was technically successful in 29
cases (97%). Three patients (10%) experienced transient neurological symptoms during the procedure. There were no
strokes. Ninety-six percent (28/29) of patients were followed up with duplex scanning. Mean follow-up was 20 months
(range 2–48). Three patients developed a greater than 90% restenosis.
Conclusion. Angioplasty is an acceptable alternative to surgery in the management of internal carotid artery restenosis
following endarterectomy.
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Introduction
Recurrent stenosis of the internal carotid artery occurs
in up to 15% of patients following carotid endarter-
ectomy (CEA).1,2 Avramovic reported that 7.4% of
patients who develop ipsilateral neurological events
following CEA have recurrent stenosis,3 prompting
treatment of these lesions.
Morbidity rates relating to surgery for restenosis of
the internal carotid artery are higher than those of
endarterectomy for primary lesions.4 – 7 Scar tissue at
the arteriotomy site makes the dissection more
traumatic and a true plane of cleavage between the
recurrent lesion and the vessel wall is often ill-
defined.5 A recent comparison of 547 primary
carotid endarterectomies with 124 redo procedures
revealed a perioperative stroke rate of 4.8% in those
undergoing reoperation versus just 0.8% in the
primary endarterectomy group.7 The same study
also reported significantly higher rates of cranial
nerve injury in the reoperation group—17% versus
5.3%.7 The increased incidence of complications has
led some authors to advocate the use of percutaneous
transluminal angioplasty in the management of this
condition.6,8
Two randomised trials have demonstrated equival-
ent stroke and death rates for surgical and endovas-
cular management of primary carotid stenosis.9,10 The
lesion associated with primary carotid stenosis is
histologically different from that seen following early
restenosis,11 making extrapolation of the results of
these trials to patients with restenosis difficult. Early
restenosis (within 2 years of CEA) of the internal
carotid artery is usually due to fibrointimal hyperpla-
sia while later (over 2 years after CEA) restenosis is
commonly attributed to recurrent atherosclerotic
plaque.11 It is hypothesised that the smooth fibrous
lesion of early restenosis is at a significantly lower risk
of distal embolisation than a friable atherosclerotic
plaque.12
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This study describes our experience with internal
carotid artery angioplasty in the management of
patients with a recurrent stenosis of the internal
carotid artery following endarterectomy.
Patients and Methods
From January 1994 to April 2001 571 consecutive
carotid endarterectomies were performed at the Mater
Hospital. The mean age of the patients was 66 years
(range 43–84 years) and 206 (36%) were female. All
patients referred to the unit with a greater than 70%
symptomatic stenosis or a greater than 90% asympto-
matic stenosis were considered for surgery. Asympto-
matic patients accounted for 165 (29%) of the
endarterectomies performed. A policy of selective
shunting based on a carotid stump pressure of less
than 50 mmHg is employed during CEA. Patching of
the carotid artery was used in only four cases in this
series (Table 1). The overall stroke and death rate for
the series was 2.1%.
All patients were entered prospectively onto a
database and followed-up post-operatively with
duplex ultrasonography at 1, 3, 6, 12 and 24 months.
All patients with greater than 90% restenosis, at the
site of the previous endarterectomy were considered
for endovascular intervention. Thirty internal carotid
artery angioplasties were attempted on 25 patients for
severe (.90%) restenosis during this period. Angio-
plasty was attempted for symptomatic restenosis in six
(20%) cases. Of these six cases, three patients pre-
sented with TIAs, two had amaurosis fugax and one
had a minor CVA with good recovery.
Carotid angioplasty was performed by a single
consultant radiologist. From the common femoral
artery a 6 mm balloon catheter was exchanged over a
guidewire and inflated for 30 s at the site of the
restenosis. Different size balloons were available if
needed but in all cases a satisfactory result was
achieved with the 6 mm device. Cerebral protection
devices or endovascular stents were not employed in
this series.
Following angioplasty, patients were recommenced
on aspirin and re-entered the carotid surveillance pro-
gramme, with duplex scanning at 3, 6, 12 and 24 months.
Statistical analysis was performed using a Toshibae
Satellite 2060 CDS Computer with GB-STAT version
6.5 statistical package (Dynamic Microsystems Inc.).
Categorical data was compared using the Chi-squared
test. A pvalue of less than0.05 was considered significant.
Results
Twenty-nine of 30 procedures were technically suc-
cessful (97%). The unsuccessful case was due to a
failure to cross the lesion with the guidewire. The
patient was subsequently treated by CEA. Of the 25
patients treated, one patient underwent angioplasty of
the contralateral side 6 months following the initial
procedure. Three patients required repeat angioplasty
for restenosis following the original intervention, one
of whom needed a third angioplasty.
All procedures were carried out within 2 years of
surgery. Mean time from surgery to angioplasty was
13 months (range 1–23 months).
One patient died from a myocardial infarction
within 30 days of undergoing carotid angioplasty. No
patient suffered a stroke as a consequence of under-
going carotid angioplasty. Three patients (10%) had a
transient neurological event, manifesting as contral-
ateral limb weakness during the procedure, which
completely resolved within minutes. Just one of these
patients was symptomatic prior to angioplasty.
Twenty-eight of the 29 successful procedures (96%)
were followed up post-angioplasty. One patient had
died from a myocardial infarction before his first
follow-up duplex scan. The average follow-up period
was 20 months (range 2–48). Three patients (10%)
developed a greater than 90% restenosis. All under-
went repeat angioplasty and two had a less than 60%
stenosis on their most recent follow-up scan. One of
Table 1. Patient characteristics.
Restenosis ðn ¼ 30Þ No restenosis ðn ¼ 545Þ P
Age 68 Years 71 Years n.s.
% Male 13/30 (43%) 306/545 (56%) n.s.
Diabetic 5/30 (16%) 94/545 (17%) n.s.
Smokers 25/30 (83%) 436/545 (80%) n.s.
Hypercholesterolaemia 18/30 (60%) 133/545 (24%) ,0.05*
Hypertensive 14/30 (46%) 300/545 (55%) n.s.
Shunted 10/30 (33%) 187/545 (34%) n.s.
Patched 1/30 (3%) 3/545 (0.5%) n.s.
*p , 0:05, Chi-squared test.
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these patients required a third angioplasty for an
asymptomatic .90% restenosis. There were two groin
haematomas (6%).
There was no significant difference between those
who required angioplasty following endarterectomy
ðn ¼ 30Þ and those who did not ðn ¼ 545Þ in terms of
age, sex, smoking status, intra-operative shunting,
patching of the carotid artery or incidence of diabetes
or hypertension (see Table 1). The group of patients
who required angioplasty for critical restenosis con-
tained a significantly greater proportion of patients
with hypercholesterolaemia than those who needed
no further intervention following surgery (p , 0:05;
Chi-squared test).
Discussion
The incidence of neurological complications in this
series is in keeping with that reported elsewhere in the
literature6,12,13 (Table 2). Our results demonstrate that
angioplasty is an alternative to re-operation in the
management of carotid artery restenosis but has its
own associated morbidity.
The 10% stroke and death rate quoted in the largest
randomised controlled trial of primary carotid angio-
plasty published to date has caused some to doubt the
suitability of this procedure for managing primary
carotid stenosis.10 Early restenoses detected within the
first two years are usually due to fibrointimal
hyperplasia and therefore less likely to embolise
during balloon angioplasty than the friable athero-
sclerotic plaque characteristic of primary carotid
stenosis.11,14
Transient neurological events occurred during the
procedure in three cases (10%). As these all resolved
before the patient left the radiology suite, it is unclear,
whether they were due to either embolisation or
transient arrest in blood flow in the internal carotid
artery during inflation of the balloon. No cerebral
protection devices were employed during any of the
procedures as carotid angioplasty in our unit began at
a time when cerebral protection was not available.
Plaque debris has been demonstrated in the cerebral
protection devices of over 50% of patients undergoing
carotid angioplasty for primary stenosis, lending
weight to the argument for routine cerebral protec-
tion.15 The use of cerebral protection devices means
using larger guide catheters, with more manipulation
in the internal carotid artery and a slightly longer
procedure time. The restenoses being treated in this
series are smooth fibrointimal lesions and the use of
such devices for lesions which are unlikely to embolise
may be unnecessary and might even lead to more
complications for the reasons outlined above.
No carotid stents were deployed in any of the
patients treated in this series. Evidence of improved
results from stenting with angioplasty has increased
over recent years9 but was, at best, ambiguous when
this series was begun in 1994. In light of more recent
reports9 we should perhaps reconsider our policy
regarding the use of stent devices during carotid
angioplasty.
Eighty percent of cases in this series were asympto-
matic. The discrepancy between this and the pro-
portion of patients undergoing primary CEA who
were asymptomatic (29%) is most probably due to the
fact that post-endarterectomy, patients were entered
into a duplex surveillance programme which
undoubtedly detected a greater proportion of asymp-
tomatic high grade stenoses. Most authors are in
agreement that symptomatic restenosis warrants
intervention but the issue of whether asymptomatic
restenoses should be treated or not remains contro-
versial. The possibility of a high grade stenosis
progressing to carotid artery occlusion has led us
and others to treat these lesions in asymptomatic
patients.16,17
Significant restenosis following angioplasty
occurred in three patients (10%). In their series of 61
patients undergoing carotid intervention for recurrent
stenosis, Abu-Rahma et al. reported a 32% incidence of
recurrent stenosis greater than 50%.18 No patient in
this series was stented. In their series of 25 carotid
Table 2. Previous series of carotid angioplasty for restenosis.
Author Year No. Stroke Further restenosis Groin haematoma
Bergeon21 1993 9 0 2 (22%) 0
Yadav22 1996 25 1 (4%) 0 1 (4%)
Leger13 2001 8 0 6 (75%) N/A
Abu-Rahma12 2001 25 4 (16%) 24% 1 (4%)
Al-Mubarak20 1998 5 0 0
Lanzino19 1999 25 0 4 (16%) 1
Vitek8 2001 110 0 0 0
Hobson6 1999 17 0 0 N/A
McDonnell 2002 30 0 3 (10%) 2 (6%)
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angioplasties for restenosis, Lanzino and colleagues
reported a significant restenosis in three of five
patients managed with angioplasty alone and just
one of the 18 patients who were treated with
angioplasty and stenting.19 In the absence of a
randomised controlled trial the issue of whether
stent placement would be of benefit in preventing
further restenosis remains controversial.
A significantly greater number of patients requiring
angioplasty for recurrent stenosis were hypercholes-
terolaemic compared to those needing no further
intervention. Hypercholesterolaemia is a well-recog-
nised risk factor in the development of atherosclerosis
and these patients may represent a subgroup of those
undergoing CEA who are at higher risk of restenosis.
Longer follow up of a larger group of patients is
necessary to resolve this issue.
Conclusion
Angioplasty of the internal carotid artery is an
acceptable alternative to surgery for the management
of restenosis following endarterectomy.
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